NeoGenomics Schedules its Q4 2013 and Full Year 2013 Earnings Release for February 19, 2014
Press Release
Read More
NeoGenomics is the First Laboratory to Offer Calreticulin (CALR) Mutation Testing for the Diagnosis and Classification of Myeloproliferative Neoplasms
Press Release
Read More
MultiOmyx™: A novel chemistry and visualization tools to aid resolution of discrepant Hodgkin Lymphoma cases. A single slide multiplex assay for the evaluation of classical Hodgkin Lymphoma
Literature
Read More
NeoGenomics Reports Record Revenue of $16.9 Million, Adjusted EBITDA of $2.2 Million and Net Income of $900K for the Third Quarter 2013
Press Release
Read More
Highly multiplexed single-cell analysis of formalinfixed, paraffin-embedded cancer tissue
Literature
Read More
MultiOmyx™: A novel multiplex methodology for the evaluation of Hodgkin Lymphoma
Literature
Read More